Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 14420
Country/Region: Zambia
Year: 2016
Main Partner: Lusaka Provincial Health Office
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $7,983,917 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $950,000
Care: TB/HIV (HVTB) $750,000
Care: Pediatric Care and Support (PDCS) $200,000
Laboratory Infrastructure (HLAB) $275,000
Strategic Information (HVSI) $250,000
Health Systems Strengthening (OHSS) $300,000
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $585,247
Testing: HIV Testing and Counseling (HVCT) $390,000
Sexual Prevention: Other Sexual Prevention (HVOP) $256,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $300,000
Treatment: Adult Treatment (HTXS) $3,227,670
Treatment: Pediatric Treatment (PDTX) $500,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 350
HTS_TST Age/sex: <1 2017 381
HTS_TST Age/sex: 1-9 2017 1,029
HTS_TST Age/sex: 1-9 2017 1,137
HTS_TST Age/sex: 10-14 Female 2017 1,251
HTS_TST Age/sex: 10-14 Female 2017 1,362
HTS_TST Age/sex: 10-14 Male 2017 833
HTS_TST Age/sex: 10-14 Male 2017 910
HTS_TST Age/sex: 15-19 Female 2017 1,527
HTS_TST Age/sex: 15-19 Female 2017 1,666
HTS_TST Age/sex: 15-19 Male 2017 1,022
HTS_TST Age/sex: 15-19 Male 2017 1,111
HTS_TST Age/sex: 20-24 Female 2017 1,534
HTS_TST Age/sex: 20-24 Female 2017 1,669
HTS_TST Age/sex: 20-24 Male 2017 1,026
HTS_TST Age/sex: 20-24 Male 2017 1,113
HTS_TST Age/sex: 25-49 Female 2017 10,697
HTS_TST Age/sex: 25-49 Female 2017 11,675
HTS_TST Age/sex: 25-49 Male 2017 7,133
HTS_TST Age/sex: 25-49 Male 2017 7,784
HTS_TST Age/sex: 50+ Female 2017 1,527
HTS_TST Age/sex: 50+ Female 2017 1,669
HTS_TST Age/sex: 50+ Male 2017 1,016
HTS_TST Age/sex: 50+ Male 2017 1,110
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 2,005
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 2,242
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,446
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,548
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 15,270
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 16,679
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 10,224
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 11,118
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 28,945
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 31,587
HTS_TST Service Delivery Point (Facility): Outpatient 2017 5,792
HTS_TST Service Delivery Point (Facility): Outpatient 2017 6,316
HTS_TST Service Delivery Point (Facility): PMTCT 2017 5,788
HTS_TST Service Delivery Point (Facility): PMTCT 2017 6,273
HTS_TST Service Delivery Point (Facility): VCT 2017 17,365
HTS_TST Service Delivery Point (Facility): VCT 2017 18,952
HTS_TST Service Delivery Point (Facility): VMMC 2017 46
HTS_TST Sum of Age/Sex disaggregates 2017 27,566
HTS_TST Sum of Age/Sex disaggregates 2017 30,069
HTS_TST Sum of Aggregated Age/Sex <15 2017 3,451
HTS_TST Sum of Aggregated Age/Sex <15 2017 3,790
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 25,494
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 27,797
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 28,945
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 31,587
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 49
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 54
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 30
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 35
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 188
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 202
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 122
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 132
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 188
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 202
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 122
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 132
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 1,286
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 1,401
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 856
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 933
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 187
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 202
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 123
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 132
HTS_TST_POS Test Result by Age: Positive: <1 2017 13
HTS_TST_POS Test Result by Age: Positive: <1 2017 16
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 38
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 44
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 81
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 87
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 49
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 62
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,848
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 2,007
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,224
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,329
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 1,132
KP_PREV By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 322
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 305
KP_PREV By key population type: People in prisons and enclosed settings (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 384
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 2,143
KP_PREV Total estimated number of key population in the catchment area 2017 2,143
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 1,132
KP_PREV_den By key population type: Males who inject drugs (Male PWID) (Denominator: Total estimated number of key population in the catchment area) 2017 322
KP_PREV_den By key population type: Men who have sex with men who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 305
KP_PREV_den By key population type: People in prisons and enclosed settings (Denominator: Total estimated number of key population in the catchment area) 2017 384
PMTCT_ART Already on ART at beginning of current pregnancy 2017 461
PMTCT_ART Already on ART at beginning of current pregnancy 2017 2,343
PMTCT_ART New on ART 2017 401
PMTCT_ART New on ART 2017 1,135
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 23,851
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 28,890
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 280
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 589
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 210
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 392
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 6
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 12
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 6
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 18
PMTCT_EID Sum of Infant Age disaggregates 2017 490
PMTCT_EID Sum of Infant Age disaggregates 2017 981
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 4,758
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 6,170
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 19,093
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 22,720
PMTCT_STAT By: Known positives at entry 2017 1,716
PMTCT_STAT By: Known positives at entry 2017 2,006
PMTCT_STAT By: Number of new positives identified 2017 1,147
PMTCT_STAT By: Number of new positives identified 2017 1,371
PMTCT_STAT Number of new ANC and L&D clients 2017 23,851
PMTCT_STAT Number of new ANC and L&D clients 2017 28,890
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 23,851
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 28,890
PMTCT_STAT Required only for DREAMS countries - By known positives: 20-24 2017 345
PMTCT_STAT Required only for DREAMS countries - By known positives: 25-49 2017 1,368
PMTCT_STAT Required only for DREAMS countries - By new positives: 20-24 2017 231
PMTCT_STAT Required only for DREAMS countries - By new positives: 25-49 2017 919
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 402
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 1,604
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 271
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 1,100
PMTCT_STAT Sum of Positives Status disaggregates 2017 2,863
PMTCT_STAT Sum of Positives Status disaggregates 2017 3,377
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 20-24 2017 4,758
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 6,170
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 25-49 2017 19,093
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 22,720
PP_PREV Aggregated Age/sex: <15 Female 2017 248
PP_PREV Aggregated Age/sex: <15 Female 2017 5
PP_PREV Aggregated Age/sex: <15 Male 2017 193
PP_PREV Aggregated Age/sex: <15 Male 2017 4
PP_PREV Aggregated Age/sex: 15+ Female 2017 1,375
PP_PREV Aggregated Age/sex: 15+ Female 2017 45
PP_PREV Aggregated Age/sex: 15+ Male 2017 969
PP_PREV Aggregated Age/sex: 15+ Male 2017 24
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 2,785
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 78
PP_PREV Total number of people in the target population 2017 2,785
PP_PREV Total number of people in the target population 2017 78
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 118
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 8
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1,024
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 65
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 6
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 590
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 15
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 1,797
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 15
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 1,797
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 7,124
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 1,585
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 1,127
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 5,138
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 458
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1,986
TB_SCREENDX Screen Result: Screened Positive for TB 2017 7,124
TB_SCREENDX Screen Results: Screened Positive for TB 2017 1,585
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 818
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 504
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 7,368
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 33,723
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 4,517
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 19,712
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 3,747
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 2,190
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 13,207
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 59,372
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 188
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 8
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,712
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 96
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 863
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 12
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 2,859
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 12
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 2,859
TX_CURR Age/Sex: <1 2017 335
TX_CURR Age/Sex: <1 2017 1,484
TX_CURR Age/Sex: <1-9 2017 5,107
TX_CURR Age/Sex: 1-9 2017 1,156
TX_CURR Age/Sex: 10-14 Female 2017 599
TX_CURR Age/Sex: 10-14 Female 2017 2,668
TX_CURR Age/Sex: 10-14 Male 2017 254
TX_CURR Age/Sex: 10-14 Male 2017 1,114
TX_CURR Age/Sex: 15-19 Female 2017 117
TX_CURR Age/Sex: 15-19 Female 2017 518
TX_CURR Age/Sex: 15-19 Male 2017 57
TX_CURR Age/Sex: 15-19 Male 2017 223
TX_CURR Age/Sex: 20-24 Female 2017 10,379
TX_CURR Age/Sex: 20-24 Female 2017 2,331
TX_CURR Age/Sex: 20-24 Male 2017 4,450
TX_CURR Age/Sex: 20-24 Male 2017 1,004
TX_CURR Age/Sex: 25-49 Female 2017 31,158
TX_CURR Age/Sex: 25-49 Female 2017 7,025
TX_CURR Age/Sex: 25-49 Male 2017 14,208
TX_CURR Age/Sex: 25-49 Male 2017 3,009
TX_CURR Age/Sex: 50+ Female 2017 2,592
TX_CURR Age/Sex: 50+ Female 2017 583
TX_CURR Age/Sex: 50+ Male 2017 1,113
TX_CURR Age/Sex: 50+ Male 2017 252
TX_CURR Aggregated Age/Sex: <15 Female 2017 1,534
TX_CURR Aggregated Age/Sex: <15 Female 2017 7,040
TX_CURR Aggregated Age/Sex: <15 Male 2017 813
TX_CURR Aggregated Age/Sex: <15 Male 2017 3,543
TX_CURR Aggregated Age/Sex: 15+ Female 2017 10,053
TX_CURR Aggregated Age/Sex: 15+ Female 2017 44,034
TX_CURR Aggregated Age/Sex: 15+ Male 2017 4,322
TX_CURR Aggregated Age/Sex: 15+ Male 2017 20,397
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 16,722
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 75,014
TX_CURR Sum of age/sex disaggregates 2017 741
TX_CURR Sum of Age/Sex disaggregations 2017 174
TX_CURR Sum of Aggregated Age/Sex <15 2017 2,347
TX_CURR Sum of Aggregated Age/Sex <15 2017 10,583
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 14,375
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 64,431
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 16,722
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 75,014
TX_NEW Aggregated Grouping by Age: <1 2017 51
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 247
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 1,269
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 121
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 672
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,572
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 9,216
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 673
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 4,978
TX_NEW By Age/Sex: <1 2017 278
TX_NEW By Age/Sex: 1-9 2017 170
TX_NEW By Age/Sex: 1-9 2017 961
TX_NEW By Age/Sex: 10-14 Female 2017 106
TX_NEW By Age/Sex: 10-14 Female 2017 494
TX_NEW By Age/Sex: 10-14 Male 2017 41
TX_NEW By Age/Sex: 10-14 Male 2017 208
TX_NEW By Age/Sex: 15-19 Female 2017 18
TX_NEW By Age/Sex: 15-19 Female 2017 96
TX_NEW By Age/Sex: 15-19 Male 2017 8
TX_NEW By Age/Sex: 15-19 Male 2017 42
TX_NEW By Age/Sex: 20-24 Female 2017 367
TX_NEW By Age/Sex: 20-24 Female 2017 1,941
TX_NEW By Age/Sex: 20-24 Male 2017 158
TX_NEW By Age/Sex: 20-24 Male 2017 831
TX_NEW By Age/Sex: 25-49 Female 2017 1,096
TX_NEW By Age/Sex: 25-49 Female 2017 6,694
TX_NEW By Age/Sex: 25-49 Male 2017 471
TX_NEW By Age/Sex: 25-49 Male 2017 3,898
TX_NEW By Age/Sex: 50+ Female 2017 91
TX_NEW By Age/Sex: 50+ Female 2017 485
TX_NEW By Age/Sex: 50+ Male 2017 36
TX_NEW By Age/Sex: 50+ Male 2017 207
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,613
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 16,135
TX_NEW Sum of Age/Sex disaggregates 2017 2,392
TX_NEW Sum of Age/Sex disaggregates 2017 14,896
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 2,613
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 16,135
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 2,518
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 24,227
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 2,518
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 24,227
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 254
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 2,422
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 253
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 2,641
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 1,007
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 9,474
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 1,004
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 9,690
TX_PVLS Numerator: Indication: Routine 2017 2,015
TX_PVLS Numerator: Indication: Routine 2017 19,380
TX_PVLS Numerator: Indication: Targeted 2017 503
TX_PVLS Numerator: Indication: Targeted 2017 4,847
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 254
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 2,422
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 253
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 2,641
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 1,007
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 9,474
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 1,004
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 9,690
TX_PVLS_den Denominator: Indication: Routine 2017 2,015
TX_PVLS_den Denominator: Indication: Routine 2017 19,380
TX_PVLS_den Denominator: Indication: Targeted 2017 503
TX_PVLS_den Denominator: Indication: Targeted 2017 4,847
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 24
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 281
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 83
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 972
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 48
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 499
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 19
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 211
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 99
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 42
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 170
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,966
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 74
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 842
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 511
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5,894
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 221
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,526
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 44
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 491
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 17
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 210
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 109
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,348
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 65
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 615
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 733
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8,451
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 313
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,619
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,220
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 14,033
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,220
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 14,033
TX_RET_den Age/Sex: <1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 24
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 281
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 83
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 972
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 48
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 499
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 19
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 211
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 8
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 99
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 42
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 170
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,966
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 74
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 842
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 511
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5,894
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 221
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,526
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 44
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 491
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 17
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 210
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 109
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,348
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 65
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 615
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 733
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 8,451
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 313
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,619
VMMC_CIRC By Age: 10-14 2017 1,734
VMMC_CIRC By Age: 15-19 2017 1,884
VMMC_CIRC By Age: 20-24 2017 3,398
VMMC_CIRC By Age: 25-29 2017 4,902
VMMC_CIRC By Age: 30-49 2017 2,375
VMMC_CIRC By Age: 50+ 2017 1,595
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 15,888
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 15,888
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 15,888
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 8,611
Cross Cutting Budget Categories and Known Amounts Total: $1,000
Water $1,000